These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Placebo reaction in neurotics rated with the SCL-90 questionnaire. Plevová J; Boleloucký Z; Bastecký J Act Nerv Super (Praha); 1979 Oct; 21(3):150-1. PubMed ID: 517085 [No Abstract] [Full Text] [Related]
4. [The AMDP scales in a phase II evaluation of psychotropic drugs]. Digonnet C; Boyer P; Puech AJ; von Frenckell R; Weil JS Acta Psychiatr Belg; 1987; 87(2):245-52. PubMed ID: 3618275 [TBL] [Abstract][Full Text] [Related]
5. [Clinical trial of mepiprazol in the treatment of neurotic inpatients (author's transl)]. Gonçalves N; Stoll KD; Fähndrich E; Urban R Pharmakopsychiatr Neuropsychopharmakol; 1978 May; 11(3):121-7. PubMed ID: 353831 [TBL] [Abstract][Full Text] [Related]
6. Drug- and placebo-treated neurotic outpatients. Pretreatment levels of manifest anxiety, clinical improvement, and side reactions. Rickels K; Downing RW Arch Gen Psychiatry; 1967 Mar; 16(3):269-72. PubMed ID: 6021472 [No Abstract] [Full Text] [Related]
7. Selected methodological issues in the evaluation of psychotropic medications in neurotic outpatients. Downing RW Psychopharmacol Bull; 1975 Jul; 11(3):19-21. PubMed ID: 1153646 [No Abstract] [Full Text] [Related]
8. [Comparison of the results of treatment of neuroses with psychotropic drugs and placebo]. Hese RT; Chmurska M Psychiatr Pol; 1982; 16(4):267-72. PubMed ID: 6760228 [No Abstract] [Full Text] [Related]
9. [The psychotropic effect of the Pyrovalerone (F-1983), placebo, the milieu therapy and mental condition of the patients in forensic psychiatry]. Söderholm S; Viukari NM; Rimón R Nervenarzt; 1976 Feb; 47(2):88-93. PubMed ID: 768789 [No Abstract] [Full Text] [Related]
10. [Neuropsychological disorders and their correction in patients with newly diagnosed pulmonary tuberculosis]. Shulgina EL; Immerman KL; Panaitova SV; Pankratova LE Probl Tuberk; 1993; (4):37-40. PubMed ID: 8127836 [No Abstract] [Full Text] [Related]
11. Pharmacotherapy and psychotherapy: paradoxes problems and progress. Formulated by the Committee on Research. Rep Group Adv Psychiatry; 1975 Mar; 9(93):263-434. PubMed ID: 1092600 [No Abstract] [Full Text] [Related]
12. [Bromazepam versus placebo. Double-blind crossover study]. Rey A; Bovet J; Schneider PB Schweiz Rundsch Med Prax; 1984 Jan; 73(5):143-8. PubMed ID: 6142517 [No Abstract] [Full Text] [Related]
13. Placebo effect of psychotropic drugs on patients and staff. Galiana M Rev Neuropsychiatr Infant; 1977; 25(5-6):329-33. PubMed ID: 331432 [No Abstract] [Full Text] [Related]
14. [Clinical effectiveness of clorazepate dipotassium (Tranxilium 20), used in a single daily dose, in neurotic disorders]. Rybakowski J; Rajewski A; Kobus A; Strzyzewski W Psychiatr Pol; 1983; 17(1):25-9. PubMed ID: 6137849 [No Abstract] [Full Text] [Related]
16. [Neurotic inhibition and transnosographic approach. Apropos of a multicenter study of carpipramine]. Ferreri M; Alby JM Encephale; 1987; 13(6):357-65. PubMed ID: 2897281 [TBL] [Abstract][Full Text] [Related]
17. Placebo use in clinical trials on psychotropic drugs in France. Guelfi JD; Boyer P; Dreyfus JF Neuropsychobiology; 1983; 9(1):20-5. PubMed ID: 6350921 [TBL] [Abstract][Full Text] [Related]
18. [The clinical aspects and psychopharmacotherapy of adaptive neurotic disorders]. Munchaeva ER; Lepp NR; Tikhonov VV; Ul'ianova EIu Ter Arkh; 1997; 69(4):65-6. PubMed ID: 9213966 [TBL] [Abstract][Full Text] [Related]
19. [Psychotropic agents in the clinical picture of internal diseases]. Raĭskiĭ VA Feldsher Akush; 1984 Feb; 49(2):37-9. PubMed ID: 6143695 [No Abstract] [Full Text] [Related]
20. Advances in drugs - boon or curse? The social implications of psychotropic drugs. Lader M R Soc Health J; 1975 Dec; 95(6):304-5. PubMed ID: 1208776 [No Abstract] [Full Text] [Related] [Next] [New Search]